Company Filing History:
Years Active: 2009-2015
Title: Tatsuya Ogawa: Innovator in Polypeptide Production
Introduction
Tatsuya Ogawa is a notable inventor based in Hofu, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of polypeptides. With a total of 2 patents, his work has implications for pharmaceutical development and therapeutic applications.
Latest Patents
Ogawa's latest patents focus on a process for producing desired polypeptides using rat cells. This innovative process involves culturing rat cells, specifically YB2/0, in a serum-free medium. The introduction of recombinant DNA encoding immunologically functional molecules allows for the production of antibodies with high antibody-dependent cell-mediated cytotoxic activity (ADCC activity). These antibodies are valuable as pharmaceutical agents, showcasing the potential of Ogawa's research in medical applications.
Career Highlights
Throughout his career, Tatsuya Ogawa has worked with prominent companies in the biotechnology sector. He has been associated with Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has contributed to his expertise in polypeptide production and biotechnology innovations.
Collaborations
Ogawa has collaborated with notable colleagues in his field, including Yoshinobu Konno and Naohisa Akashi. These partnerships have likely enhanced his research and development efforts, leading to advancements in polypeptide production techniques.
Conclusion
Tatsuya Ogawa's contributions to the field of biotechnology, particularly in polypeptide production, highlight his role as an innovator. His patents and collaborations reflect a commitment to advancing medical science through innovative processes.